Sermorelin 5 mg
Main Image

Sermorelin 5 mg

Steroids Kalpa Pharmaceuticals LTD India Kalpa

$24.00

Kalpa Pharmaceuticals Sermorelin 5 mg – GHRH Analog for Growth Hormone Research

✔ High-purity lyophilized powder ✔ 5 mg per 2 mL vial ✔ GHRH (1-29) analog ✔ USA & International shipping

Kalpa Pharmaceuticals Sermorelin 5 mg is a synthetic analog of growth hormone-releasing hormone (GHRH), specifically the biologically active fragment GHRH (1-29). Each 2 mL vial contains 5 mg of lyophilized Sermorelin, designed for reconstitution in research settings investigating growth hormone regulation and pulsatile secretion patterns.

Sermorelin acts directly on the pituitary somatotrophs to stimulate endogenous growth hormone release, mimicking the natural GHRH mechanism. For researchers studying the hypothalamic-pituitary axis, this peptide provides a targeted tool for GH pulse manipulation. Explore similar research compounds like Ipamorelin 5 mg or Tesamorelin 5 mg.

What Makes Kalpa Pharmaceuticals Sermorelin Unique?

As a GHRH analog, Sermorelin represents the N-terminal fragment of endogenous GHRH (1-44), retaining full biological activity while offering a shorter peptide sequence. Unlike GHRP compounds that act on the ghrelin receptor, Sermorelin targets GHRH receptors directly, providing a distinct mechanism for stimulating GH release.

For performance-focused research, Sermorelin is often studied in combination with GHRP analogs to evaluate synergistic effects on GH pulsatility. The 5 mg dosage provides flexibility for both acute and extended research protocols. Researchers may also compare Sermorelin with Tesamorelin to evaluate differences between GHRH analogs.

Benefits of Kalpa Pharmaceuticals Sermorelin for Research

  • ✔ Direct GHRH receptor agonist for targeted GH research
  • ✔ Biologically active fragment of endogenous GHRH
  • ✔ 5 mg lyophilized powder for reconstitution flexibility
  • ✔ Suitable for subcutaneous administration research
  • ✔ Can be stacked with GHRP compounds for synergy studies
Research Grade

Kalpa Pharmaceuticals Sermorelin 5 mg is intended for laboratory research only. Not for human consumption or clinical use.

External research on Sermorelin's mechanisms can be explored via PubMed for peer-reviewed studies.

Dispatched within 24 hours in plain, discreet packaging.

Additional Information

Categories:
Brand: Kalpa Pharmaceuticals LTD, India
Manufacturer: Kalpa Pharmaceuticals LTD, India
Dosage Info: <div class="tab-pane fade" id="offer-tabbody--dosage-and-usage" role="tabpanel"> <section class="tab-panel" id="panel-usage"> <h2>Dosage &amp; Usage Guidelines for Research</h2> <div class="info-card warning"> <p><strong>For laboratory research use only.</strong> Not for human consumption. Reconstitution and handling must be performed by qualified personnel using sterile techniques.</p> </div> <h3>Reconstitution Protocol</h3> <ul class="usage-highlights"> <li>✔ Add 2-3 mL bacteriostatic water to the 5 mg vial</li> <li>✔ Swirl gently; do not shake</li> <li>✔ Store reconstituted peptide at 2-8°C and use within 30 days</li> </ul> <p>The standard reconstitution yields a concentration of approximately 1.67-2.5 mg/mL (1670-2500 mcg/mL). For precise dosing, researchers should calculate based on desired mcg per injection volume.</p> <h3>Typical Research Parameters</h3> <p>In animal models, Sermorelin is often administered at dosages ranging from 100-500 mcg per injection. Due to its short half-life, multiple daily administrations are common in prolonged studies. Subcutaneous injection is the standard route for systemic absorption research.</p> <ul> <li>✔ Subcutaneous injection: 100-500 mcg once or twice daily</li> <li>✔ Research models: Rodent dosing typically scaled by body weight</li> <li>✔ Study duration: 4-8 weeks for chronic GH elevation studies</li> </ul> <h3>Combination Research</h3> <p>Sermorelin is frequently studied alongside GHRP compounds like Ipamorelin or GHRP-2 to evaluate synergistic effects on GH release. This combination can produce amplified GH pulses compared to either peptide alone. For stacking protocols, <a href="/kalpa-1715/ipamorelin-5-mg-90947">Ipamorelin 5 mg</a> can be reconstituted and administered concurrently.</p> <div class="info-card"> <p><strong>Note:</strong> Dosages mentioned are for research purposes only. Individual response varies in animal models. Always follow institutional animal care guidelines when conducting in vivo research.</p> </div> <h3>What to Avoid During Research</h3> <ul> <li>❌ Do not use if the lyophilized cake appears discolored or collapsed</li> <li>❌ Avoid administration with high-fat meals in oral absorption studies</li> <li>❌ Do not mix with strong acidic or basic solutions</li> <li>❌ Avoid repeated freeze-thaw cycles after reconstitution</li> </ul> </section> </div>
Reviews:
(0 customer reviews)

Technical Details

Peptide Type
Synthetic GHRH Analogue
Peptide Sequence
YADAIFTNSYRKVLGQLSARKLLQDIMSR-NH₂
Peptide Length
29 Amino-Acid Residues
Terminal Form
C-Terminal Amide (-NH₂)
Structural Origin
Human GHRH Residues 1–29
Molecular Formula
C₁₄₉H₂₄₆N₄₄O₄₂S
Molecular Weight
3357.9 g/mol
CAS Number
86168-78-7
PubChem CID
16129608
Receptor Target
GHRH Receptor (GHRHR)
Signaling Pathway
GHRHR / Growth Hormone Axis

Chat on WhatsApp